Anthony W. Tolcher MD

Clinical Trials

• Chemotherapy in Treating Patients With Advanced Solid Tumors Start of enrollment: 1998 Jul 01

  Completed

  Phase 1

• Chemotherapy in Treating Patients With Advanced Solid Tumors Start of enrollment: 1998 Oct 01

  Completed

  Phase 1

• Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer Start of enrollment: 2000 Jun 01

  Completed

  Phase 1, Phase 2

• Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer Start of enrollment: 2000 Jun 01

  Completed

  Phase 1

• Erlotinib in Treating Patients With Advanced Kidney Cancer Start of enrollment: 2002 Jun 01

  Completed

  Phase 2

• Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 2002 Oct 01

  Completed

  Phase 1, Phase 2

• Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease Start of enrollment: 2006 Jul 01

  Completed

  Phase 1

• Safety Study of CALAA-01 to Treat Solid Tumor Cancers Start of enrollment: 2008 May 01

  Terminated

  Phase 1

• A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors Start of enrollment: 2010 Dec 01

  Completed

  Phase 1

• Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies Start of enrollment: 2013 Mar 01

  Completed

  Phase 1, Phase 2

• Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma Start of enrollment: 2013 Jul 01

  Terminated

  Phase 1

• Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma

  TERMINATED

  PHASE1

• Phase 1 of EC1169 In Patients With Recurrent MCRPC Start of enrollment: 2014 May 01

  Completed

  Phase 1

• A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer Start of enrollment: 2015 Sep 01

  Completed

  Phase 1

• Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors Start of enrollment: 2017 Nov 28

  Active, not recruiting

  Phase 1

• A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer Start of enrollment: 2018 Oct 16

  Completed

  Phase 1

• TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers Start of enrollment: 2019 Apr 10

  Completed

  Phase 1

• Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A Start of enrollment: 2019 May 01

  Recruiting

  Phase 1

• Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2021 Jun 11

  Terminated

  Phase 1

  Roles: Contact

• A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors Start of enrollment: 2022 Aug 25

  RECRUITING

  PHASE1, PHASE2

  Roles: Contact

• A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors Start of enrollment: 2018 Aug 29

  RECRUITING

  PHASE1, PHASE2

  Roles: Contact, Principal Investigator

• A Study of Injection HB0025 in Patients With Advanced Solid Tumors Start of enrollment: 2021 Mar 10

  Recruiting

  Phase 1

  Roles: Contact

• Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301) Start of enrollment: 2019 Dec 20

  ACTIVE_NOT_RECRUITING

  PHASE1

  Roles: Principal Investigator

• Join now to see all